Gennex Laboratories

Gennex Laboratories EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Gennex Laboratories (531739.BO) as of Oct 18, 2026 is -4.52. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -9.73 — a change of -53.59% (higher).

EV/FCF

-4.52

YoY

-53.59%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Gennex Laboratories is 2026 -4.52 . EV/FCF (Enterprise Value to Free Cash Flow) of Gennex Laboratories was 2025 -9.73 . It decreases by -53.59% higher compared to the previous year.

The Gennex Laboratories EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
33.28 M INR
Jan 1, 2020
-153.72 INR
Jan 1, 2021
-186.65 INR
Jan 1, 2022
27.25 INR
Jan 1, 2023
-18.13 INR
Jan 1, 2024
-4.23 INR
Jan 1, 2025
-9.73 INR
Jan 1, 2026
-4.52 INR
The Gennex Laboratories EV/FCF history
YEAREV/FCFYoY
-4.52-53.59%
-9.73+130.19%
-4.23-76.68%
-18.13-166.56%
27.25-114.60%
-186.65+21.42%
-153.72-100.00%
33.28 M+26.63 M%
124.99-146.05%
-271.44-290.43%
142.54-101.76%
-8,119.76+1,183.17%
-632.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gennex Laboratories Stock analysis

What does Gennex Laboratories do? Gennex Laboratories Ltd is a pharmaceutical manufacturer headquartered in Hyderabad, India, listed on the stock exchange in 1996. The company operates through its Pharmaceutical Products segment, specializing in the production of bulk drugs, intermediates, and biotech products. Its robust portfolio includes active pharmaceutical ingredients such as Guaifenesin, Methocarbamol, Phenazopyridine Hcl, Fluconazole, Mephenesin, Chlorphenesin, and Melitracen Hcl. These products serve various therapeutic areas, including expectorants, muscle relaxants, analgesics, anti-fungals, and antidepressants. Gennex Laboratories utilizes manufacturing facilities in India to supply both domestic and international markets, catering to the global demand for essential healthcare solutions within the health care sector. Gennex Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gennex Laboratories stock

EV/FCF (Enterprise Value to Free Cash Flow) of Gennex Laboratories is -4.52 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Gennex Laboratories changed from -9.73 to -4.52, representing a -53.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Gennex Laboratories since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Gennex Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Gennex Laboratories

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Gennex Laboratories